Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion type Assertion NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_head.
- NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion description "[Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_provenance.
- NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion evidence source_evidence_literature NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_provenance.
- NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion SIO_000772 22355347 NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_provenance.
- NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion wasDerivedFrom befree-20140225 NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_provenance.
- NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_assertion wasGeneratedBy ECO_0000203 NP524514.RAuLnVF0ssaObdIBuNynk8FX0_jtuDld6CcefVK_oGU7c130_provenance.